SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trading with high volatility as investors weigh the potential impact of an invite-only Cybercab event, with the community deeply divided between bullish expectations for long-term autonomous commercialization and bearish concerns that the event will trigger a 'sell-the-news' pullback. Much of the discourse is focused on the lack of a public livestream and ongoing regulatory uncertainty, fueling debates over whether the stock is primed for a short squeeze or a significant post-event decline.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors express bullish sentiment ahead of the upcoming earnings report, bolstered by a new equipment deal with HPE to scale AI infrastructure. While some traders debate valuation and the sustainability of AI-related revenue, many view the stock as undervalued and anticipate a significant price move around the earnings date.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon Athletica shares are facing significant downward pressure following second-quarter financial results that missed revenue expectations and a subsequent reduction in full-year guidance. Traders are actively debating the company's long-term prospects, with many expressing skepticism regarding brand health and competition, while others consider the steep decline a potential turnaround or buyout opportunity.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs shares received attention following a second-quarter report that featured a revenue and earnings beat, though a softer third-quarter outlook tempered some investor enthusiasm. While some traders expressed frustration with the guidance and broader volatility in the space sector, many remain bullish on the company's backlog, recurring revenue, and long-term potential in defense and AI-driven geospatial intelligence.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as traders debate the company's aggressive Bitcoin accumulation strategy, with bullish investors citing high potential for gains amid crypto market strength, while bears express skepticism regarding share dilution and the volatility of the underlying assets. Discussions are heavily focused on the company's recent price action and the ongoing debate over whether to hold the stock or the digital asset directly.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign shares are attracting attention following a fiscal second-quarter earnings beat and an upward revision to full-year guidance, driven by momentum in its Intelligent Agreement Management (IAM) platform. While many traders remain bullish on the company's AI-led growth strategy, skeptics express concerns over long-term competition from free alternatives and potential obsolescence.

Frontera Energy Corp. engages in the exploration, development, production, transportation, storage, and sale of oil and natural gas. It operates interests in exploration and production blocks in Colombia, Ecuador and Guyana, and pipeline and port facilities in Colombia. The company was founded on April 10, 1985 and is headquartered in Calgary, Canada.

Frontera Energy Corporation - Ordinary Shares New

Investors are closely watching the company for anticipated announcements regarding the strategic sale or spin-off of its infrastructure business and updates on its Guyana exploration licenses. The stock is currently trading based on speculation about these potential catalysts and the company's valuation gap compared to its underlying asset value.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Investors are closely watching preliminary earnings results and the company's multi-billion dollar stake in eBay, while continuing to speculate about potential short squeezes, share buybacks, and future moves by management. The conversation remains highly polarized, with many users debating the company's valuation and the significance of recent convertible note exchanges.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup shares are facing heavy selling pressure following an earnings report that featured weaker-than-expected guidance and a surprise 36% dividend cut as the company prioritizes debt reduction. While some traders view the stock as a deeply undervalued defensive play with strong brand recognition, others remain bearish, citing poor management and structural headwinds in the packaged food sector.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

The primary catalyst for Adobe is the appointment of Anil Chakravarthy as the company's next CEO, effective December 1, as part of a leadership transition with current CEO Shantanu Narayen. Community reaction is divided, with some traders praising the internal hire and focus on enterprise software while others express skepticism regarding the timing and the company's ability to compete with generative AI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)

Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of REGENXBIO Inc. (NASDAQ: RGNX) against certain of its officers and directors for alleged breaches of fiduciary duty. Shareholders who have held REGENXBIO shares continuously since prior to February...

RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy

REGENXBIO stock plunges 25% after the FDA places a clinical hold on RGX-121 for MPS II, following asymptomatic spine MRI findings in five participants.

REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli

REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli PR Newswire ROCKVILLE, Md., Aug. 25, 2026 ROCKVILLE, Md., Aug. 25, 2026 /PRNewswire/ -- REGENXBIO Inc.(Nasdaq: RGNX) today announced the appointment...

Regenxbio’s RGX-121 Setback Carries A Potential Cash Risk, Warns Clear Street

Equity

Clear Street said the FDA decision would significantly delay Regenxbio’s resubmission of its application and a potential voucher that could bring in additional cash.


RGNX Stock On Track For Worst Day In Over Three Months — BofA Says Buy Despite ‘Disappointing’ FDA Hold On Gene Therapy

BofA called the clinical hold on RGX-121 disappointing and a reversal of July’s progress but kept a $15 price target on the stock. 


Why Did RGNX Stock Crash Today?

Regenxbio said the FDA has placed a clinical hold on its Hunter syndrome therapy after the discovery of unusual spine MRI findings in five participants in a study.


Futures Slide Ahead Of "Pivotal Week" With Nvidia Earnings. Warsh Speech On Deck

Futures Slide Ahead Of "Pivotal Week" With Nvidia Earnings. Warsh Speech On Deck

 Futures are lower with Tech underperforming as the market focuses on NVDA / MRVL earnings this week; while the AI theme is pressured globally and memory stocks slump driven by a slide in the Kospi. Futures...

Regenxbio Hits Regulatory Roadblock After FDA Puts RGX-121 on Hold

Regenxbio stock drops over 23% following an FDA clinical hold on its Hunter Syndrome gene therapy RGX-121 due to spine MRI findings.read more...

REGENXBIO Announces Regulatory Update on RGX-121 for MPS II

REGENXBIO Announces Regulatory Update on RGX-121 for MPS II REGENXBIO Announces Regulatory Update on RGX-121 for MPS II PR Newswire ROCKVILLE, Md., Aug. 24, 2026 ROCKVILLE, Md., Aug. 24, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today provided an update on its investigational gene therapy...

Regenxbio (RGNX) Beats Q2 Earnings and Revenue Estimates

Regenxbio (RGNX) delivered earnings and revenue surprises of +258.33% and +16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of $0.43 up 131.16% YoY
• Reported revenue of $108.02M up 405.73% YoY
• REGENXBIO expects its balance in cash, cash equivalents, and marketable securities as of June 30, 2026, plus July 2026 proceeds, are sufficient to fund operations for REGENXBIO into Q4 2027.

REGENXBIO faces structural revenue headwinds from expired ZOLGENSMA patents, a significant reduction in cash reserves during the first half of 2026, and increased general and administrative expenses for REGENXBIO.

REGENXBIO achieved positive clinical trial results for RGX-202, secured a $100 million milestone payment from AbbVie, and received favorable regulatory feedback from the FDA regarding the RGX-121 BLA resubmission.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Feed

News

Sentiment

Earnings

Fundamentals

Info

RGNX Regenxbio Inc

Fundamentals

Latest RGNX News